91 related articles for article (PubMed ID: 2233336)
1. Bioassay of paf-acether by rabbit platelet aggregation.
Bossant MJ; Ninio E; Delautier D; Benveniste J
Methods Enzymol; 1990; 187():125-30. PubMed ID: 2233336
[No Abstract] [Full Text] [Related]
2. Rapid and selective measurement of platelet-activating factor using a quantitative bioassay of platelet aggregation.
Ammit AJ; O'Neill C
J Pharmacol Methods; 1991 Aug; 26(1):7-21. PubMed ID: 1921410
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor-acether is a component of human follicular fluid.
Amiel ML; Testart J; Benveniste J
Fertil Steril; 1991 Jul; 56(1):62-5. PubMed ID: 1829690
[TBL] [Abstract][Full Text] [Related]
4. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
5. Bioassay of platelet-activating factor by release of [3H]serotonin.
Henson PM
Methods Enzymol; 1990; 187():130-4. PubMed ID: 2233338
[No Abstract] [Full Text] [Related]
6. Platelet aggregating activity in human embryo culture media free of PAF-acether.
Amiel ML; Duquenne C; Benveniste J; Testart J
Hum Reprod; 1989 Apr; 4(3):327-30. PubMed ID: 2715310
[TBL] [Abstract][Full Text] [Related]
7. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia.
Prevost MC; Cariven C; Simon MF; Chap H; Douste-Blazy L
Biochem Biophys Res Commun; 1984 Feb; 119(1):58-63. PubMed ID: 6422938
[TBL] [Abstract][Full Text] [Related]
10. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
11. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Touqui L; Jacquemin C; Vargaftig BB
Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
[TBL] [Abstract][Full Text] [Related]
12. Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins.
Khan SN; Lane PA; Smith AD
Eur J Pharmacol; 1985 Jan; 107(2):189-98. PubMed ID: 3920056
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor.
Collier M; O'Neill C; Ammit AJ; Saunders DM
Hum Reprod; 1988 Nov; 3(8):993-8. PubMed ID: 3204154
[TBL] [Abstract][Full Text] [Related]
14. Development of a sensitive and specific 14C-serotonin release assay for platelet-activating factor (PAF) in human neutrophils.
Müller S; Nigam S
J Lipid Mediat; 1990; 2(6):329-41. PubMed ID: 2133275
[TBL] [Abstract][Full Text] [Related]
15. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
16. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
17. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
18. PAF-acether (PAF) in Ehrlich ascites tumour cells.
Marathe GK; Krishnakanta TP; D'Souza CJ
J Lipid Mediat; 1990; 2(5):257-62. PubMed ID: 2133270
[TBL] [Abstract][Full Text] [Related]
19. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Uemura Y; Ou M; Iwamoto N; Mori T
Life Sci; 1994; 54(6):429-37. PubMed ID: 8295490
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
